EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 128 filers reported holding EXELIXIS INC in Q4 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,084,000 | +15.3% | 877,536 | -1.1% | 0.02% | +7.1% |
| Q3 2016 | $11,345,000 | +65.0% | 887,034 | +0.7% | 0.01% | +55.6% |
| Q2 2016 | $6,877,000 | +109.6% | 880,601 | +7.3% | 0.01% | +125.0% |
| Q1 2016 | $3,281,000 | -26.8% | 820,346 | +3.2% | 0.00% | -33.3% |
| Q4 2015 | $4,482,000 | +1.1% | 794,714 | +0.5% | 0.01% | 0.0% |
| Q3 2015 | $4,435,000 | +69.1% | 790,552 | +13.3% | 0.01% | +100.0% |
| Q2 2015 | $2,623,000 | +90.3% | 697,676 | +30.1% | 0.00% | +50.0% |
| Q1 2015 | $1,378,000 | +77.6% | 536,366 | -0.4% | 0.00% | +100.0% |
| Q4 2014 | $776,000 | -24.1% | 538,659 | -19.4% | 0.00% | 0.0% |
| Q3 2014 | $1,023,000 | -53.1% | 668,659 | +3.8% | 0.00% | -66.7% |
| Q2 2014 | $2,183,000 | +14.4% | 643,952 | +19.5% | 0.00% | 0.0% |
| Q1 2014 | $1,908,000 | -38.3% | 538,943 | +6.8% | 0.00% | -40.0% |
| Q4 2013 | $3,092,000 | +3.0% | 504,470 | -2.2% | 0.01% | 0.0% |
| Q3 2013 | $3,001,000 | +35.0% | 515,714 | +5.3% | 0.01% | +25.0% |
| Q2 2013 | $2,223,000 | – | 489,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |